Shenglin Huang

机构：Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0003-1279-0794

发表论文 286 篇 · 总被引 15282 次 · h-index 57

代表论文

• Optimized circular RNA vaccines for superior cancer immunotherapy (2024 · Theranostics · 被引 45)
• Circular RNA landscape in extracellular vesicles from human biofluids (2024 · Genome Medicine · 被引 28)
• LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2/SRSF1/VEGF axis (2024 · Cancer Letters · 被引 17)
• The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy (2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 17)
• Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial (2024 · Signal Transduction and Targeted Therapy · 被引 15)
• p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy (2025 · Proceedings of the National Academy of Sciences · 被引 11)